window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

oncology research

  • Clinical Trials,Oncology,Research & Development

    Heidelberg Pharma sees complete remissions in HDP-101 multiple myeloma trial

    Heidelberg Pharma has reported further clinical activity from its Phase [...]

    November 6, 2025
  • Artificial Intelligence,Clinical studies,Digital Health,Global health,Oncology,Partnerships & Funding,Women's Health

    SpotitEarly and Hackensack Meridian Health partner to advance early detection with trained dogs

    SpotitEarly, a US-based early cancer detection startup, has announced a [...]

    October 1, 2025
  • Clinical Trials,Oncology,Patient Centricity,Technology and platforms

    START launches Hope Hub to improve access to early-phase cancer trials

    START unveils the Hope Hub, a digital platform connecting patients, [...]

    July 2, 2025
  • Clinical Trials,Drug Development,Regulatory Affairs

    Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois

    As oncology research continues to evolve, the focus is increasingly [...]

    May 30, 2025
  • Clinical Trials

    Heidelberg Pharma advances lead candidates and extends cash runway

    April 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top